Article info

Download PDFPDF

Rapid and sustained response to immune checkpoint inhibition in cutaneous squamous cell carcinoma after allogenic hematopoietic cell transplant for sézary syndrome

Authors

  • Karam Khaddour Division of Medical Oncology, Department of MedicineWashington University in Saint Louis 660 South Euclid Avenue, Campus Box 8056 63110 St. Louis MO USA Division of Medical Oncology, Bone Marrow Transplantation and Leukemia, Department of MedicineWashington University in Saint Louis St. Louis USA PubMed articlesGoogle scholar articles
  • Amy Musiek Division of Dermatology, Department of MedicineWashington University in Saint Louis St. Louis USA PubMed articlesGoogle scholar articles
  • Lynn A. Cornelius Division of Dermatology, Department of MedicineWashington University in Saint Louis St. Louis USA Alvin J. Siteman Cancer Center St. Louis USA PubMed articlesGoogle scholar articles
  • Farrokh Dehdashti Division of Nuclear Medicine, Department of RadiologyWashington University in Saint Louis St. Louis USA Alvin J. Siteman Cancer Center St. Louis USA PubMed articlesGoogle scholar articles
  • Peter Westervelt Division of Medical Oncology, Bone Marrow Transplantation and Leukemia, Department of MedicineWashington University in Saint Louis St. Louis USA Alvin J. Siteman Cancer Center St. Louis USA PubMed articlesGoogle scholar articles
  • Ryan Fields Section of Surgical Oncology, Department of SurgeryWashington University in Saint Louis St. Louis USA Alvin J. Siteman Cancer Center St. Louis USA PubMed articlesGoogle scholar articles
  • George Ansstas Division of Medical Oncology, Department of MedicineWashington University in Saint Louis 660 South Euclid Avenue, Campus Box 8056 63110 St. Louis MO USA Alvin J. Siteman Cancer Center St. Louis USA PubMed articlesGoogle scholar articles

Citation

Khaddour K, Musiek A, Cornelius LA, et al
Rapid and sustained response to immune checkpoint inhibition in cutaneous squamous cell carcinoma after allogenic hematopoietic cell transplant for sézary syndrome
Online issue publication 
January 08, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.